Iproniazid [CAS 54-92-2]

Iproniazid is an orally active, irreversible, non-selective monoamine oxidase (MAO) inhibitor. Iproniazid inhibits MAO activity and enhances Rotenone -induced Apoptosis. Iproniazid modulates neurotransmitter levels, affects neuronal function, induces hepatic necrosis, and interferes with the endocrine system. Iproniazid can be used in the research of depression, Parkinson's disease, and hepatotoxicity[1][2][3][4][5][6][7].

[54-92-2]

C9H13N3O

179.22

O=C(C1=CC=NC=C1)NNC(C)C

Apoptosis; Monoamine Oxidase

10mM

99.91

DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL

-20°C (Powder, stored under nitrogen)

Blue Ice

H302, H315, H319, H335

H302, H315, H319, H335